Abstract
Beta-hydroxy-beta-methylbutyrate (HMB) is the natural metabolite of leucine. There are very few studies which report on the temporal relationship between HMB levels following supplementation and muscle health. The objectives of this study were: (1) to investigate the effect of oral nutritional supplement (ONS) containing HMB on urinary HMB levels and (2) to determine the association between changes in HMB levels and muscle health. Urinary HMB levels indicate long-term HMB intake because levels increase and reach steady state over time. Data for analysis were derived from the SHIELD study, which was a randomised, double-blind, placebo-controlled trial consisting of 811 community-dwelling older adults at risk of malnutrition in Singapore. Participants were randomly allocated to either ONS containing HMB (0.74 g calcium HMB per serving) or placebo. Both groups received dietary counselling and consumed study products twice a day for 180 days. Data were collected at baseline, as well as days 30, 90, and 180. ONS containing HMB significantly increased urinary HMB levels in the intervention group over 180 days compared to placebo (p < 0.0001). The changes in HMB levels in the intervention group were positively correlated with changes in the total balance test score at day 90, ASMI, the SPPB score, and the score for the five chair stands at day 180, and negatively correlated with time taken for five chair stands at day 180 (all p ≤ 0.0425). There were also tendencies of positive association between HMB levels and calf circumference at day 90 and fat free mass at day 180 (both p ≤ 0.0591). However, no such associations were seen in the placebo group for the same measures above (all p ≥ 0.2537). In conclusion, consuming ONS containing HMB in community-dwelling older adults at risk of malnutrition significantly increased urinary HMB levels and correlated with improved muscle health. Therefore, ONS containing HMB should be incorporated in interventions for older adults with poor muscle health.
Author Contributions
Conceptualization, S.L.T., D.T.T.H., G.B., Y.L.L., C.H.H., M.C., W.L.C., N.C.T. and S.T.H.C.; methodology, S.L.T. and S.T.H.C.; formal analysis, J.O. and G.B.; investigation, S.T.H.C.; data curation, S.L.T.; writing—original draft preparation, S.L.T. and S.T.H.C.; writing—review and editing, S.L.T., D.T.T.H., J.O., G.B., S.P., Y.L.L., C.H.H., M.C., W.L.C., N.C.T. and S.T.H.C. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by Economic Development Board of Singapore (Grant number: COY-15-IDS-LL/160011), Abbott Nutrition Research and Development, and Changi General Hospital.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the SingHealth Centralized Institutional Review Board in Singapore reference number 2017/2273.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
All relevant data are within the article.
Conflicts of Interest
S.L.T., D.T.T.H., J.O., G.B., S.P. and Y.L.L. are employees of Abbott. S.T.H.C. has previously received study co-funding, travel grant, and honoraria from Abbott Nutrition. All other authors declare no conflict of interests.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).